Market revenue in 2023 | USD 10.8 million |
Market revenue in 2030 | USD 21.1 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Surgery |
Fastest growing segment | Intralesional injections |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications |
Key market players worldwide | Bausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 36.11% in 2023. Horizon Databook has segmented the Argentina basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.
In Argentina, the basal cell carcinoma treatment market is witnessing initiatives to improve early detection rates, driven by inadequate sun protection habits. In January 2024, Topazium, in collaboration with Medicus and Andrómaco, introduced SkinGuard.
An AI tool aimed at aiding healthcare professionals in identifying suspicious skin lesions, especially on beaches where sun exposure is high. SkinGuard uses AI to assess images of moles, providing probabilities of malignancy for different types of skin cancer.
This initiative reflects a growing awareness of the importance of early detection in reducing the burden of skin cancer. The market in Argentina is characterized by such innovative approaches to BCC treatment, indicating a dynamic landscape focused on improving patient outcomes.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina basal cell carcinoma treatment market , including forecasts for subscribers. This country databook contains high-level insights into Argentina basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account